Amplicon details |
||
Amplicon: |
173 bp | |
1 ggatctcctg tcatctcacc ttgctcctgc cgagaaagta tccatcatgg 51 ctgatgcaat gcggcggctg catacgcttg atccggctac ctgcccattc 101 gaccaccaag cgaaacatcg catcgagcga gcacgtactc ggatggaagc 151 cggtcttgtc gatcaggatg atc |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
NRN_DJ063275 | nrnl1 | Vector for anlyzing splicing pattern. | 5783 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DL256711 | nrnl1 | CAEV-BASED VECTOR SYSTEMS. | 5729 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DD237889 | nrnl1 | Novel transformant. | 9141 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
JN948503.1 | emblreltgn | Mus musculus targeted KO-first, con... | 38484 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
NRN_DL256707 | nrnl1 | CAEV-BASED VECTOR SYSTEMS. | 7579 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DJ045710 | nrnl1 | A versatile strategy using recombin... | 9461 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_E12566 | nrnl1 | DNA which suppresses the expression... | 3326 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_EA001260 | nrnl1 | Sequence 23 from patent US 7122348. | 7856 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_EA001258 | nrnl1 | Sequence 21 from patent US 7122348. | 7871 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_EA001259 | nrnl1 | Sequence 22 from patent US 7122348. | 7828 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DM165927 | nrnl1 | Ocular Gene Therapy Using Avalanche... | 7166 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DM204701 | nrnl1 | Transformant producing a fusion pro... | 5870 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
JN948504.1 | emblreltgn | Mus musculus targeted KO-first, con... | 40476 bp | Mus musculus | QL-ELE-00-003 | 173 bp | View |
NRN_DM119557 | nrnl1 | Targeting Cells With Altered miRNA ... | 6606 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DM467535 | nrnl1 | Plasmid vector for transforming fun... | 5886 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DI122223 | nrnl1 | Vector for Preparation of Transform... | 9762 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DD260221 | nrnl1 | An expression vector which can cont... | 17913 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DJ045712 | nrnl1 | A versatile strategy using recombin... | 9505 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_DI116080 | nrnl1 | TISSUE PROTECTIVE CYTOKINE RECEPTOR... | 6059 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
NRN_CQ821461 | nrnl1 | Sequence 17 from Patent EP1428886. | 7235 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.